Loading...
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling
Major roadblocks to developing effective progesterone receptor (PR)-targeted therapies in breast cancer include the lack of highly-specific PR modulators, a poor understanding of the pro- or anti-tumorigenic networks for PR isoforms and ligands, and an incomplete understanding of the cross talk betw...
Saved in:
| Published in: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Impact Journals LLC
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5796974/ https://ncbi.nlm.nih.gov/pubmed/29435103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21378 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|